Fox Chase Cancer Center
10/09/2025 | Press release | Distributed by Public on 10/09/2025 11:26
Temple Health Announces Fox Chase Leadership Appointments to Further Enhance Cancer Care Through Integration
October 09, 2025
Robert Uzzo, MD, MBA
Robert Uzzo, MD, MBA's role as President & CEO of Fox Chase Cancer Center will now extend beyond the American Oncologic Hospital and include the Institute for Cancer Research, uniting Fox Chase's dual missions of cancer care and research and unlocking limitless possibilities for scientific advancement while broadening Fox Chase's impact well beyond our region.
An internationally recognized urologic cancer surgeon and researcher, Dr. Uzzo has a proven track record of success at building and strengthening innovative research and academic programs. As President & CEO of Fox Chase Cancer Center, he has significantly advanced the institution's clinical, research, operational, and financial performance, and further accelerated the pace of cancer discovery and delivery for our patients.
Leadership Transitions
For nearly 35 years, Jonathan Chernoff, MD, PhD has been a valuable part of Fox Chase Cancer Center, supporting the strategic direction of the institution's research while making essential contributions to his own laboratory. Dr. Chernoff will now be transitioning from his position of Cancer Center Director to focus on his own research, and will become Cancer Center Director, Emeritus as we initiate a national search for a new Cancer Center Director.
During the search, David Wiest, PhD will serve as Interim Cancer Center Director. Dr. Wiest has made invaluable contributions to Fox Chase Cancer Center, and his leadership will continue to advance our research efforts during this transition period.
In addition, Joel Helmke, MSHP, FACHE, currently Fox Chase's Chief Operating Officer, has assumed COO responsibilities for both the Institute for Cancer Research and the American Oncologic Hospital.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427
Fox Chase Cancer Center published this content on October 09, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 09, 2025 at 17:26 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]